Market News AIOpen the app

IRD stock news · Opus Genetics, Inc.

Stories about Opus Genetics, Inc. (IRD) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IRD

Follow Opus Genetics, Inc. (IRD) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IRD
Free on the App Store and Google Play, or on the web.
  1. Oct 15, 2026, 5:30 PM ET · Market

    Opus Genetics, Inc. shares new information about its clinical trials.

    Neutral

    Opus Genetics shared presentations on clinical data from 2 ongoing trials. The filing gives no findings, so it does not change the company’s outlook.

  2. Sep 9, 2026, 10:16 AM ET · Market

    Caleres had a strong second quarter, and shares of Opus Genetics, Flotek Industries, and others also went up on Wednesday.

    Good for IRD

    Opus Genetics announced positive early trial results and its shares jumped sharply on the update.